Schedule 13G ownership disclosure

Mirati Therapeutics Inc

Security class unavailable · CUSIP: 60468T105

Event date: 2023-12-18

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
7,396,979
Percent of class
10.5000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000935836-23-000742
Form type
SC 13G/A
Filer
EcoR1 Capital, LLC
CIK
CIK 1587114
Filed
Dec 27, 2023
Reporting period
Dec 18, 2023
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub